| ESA use in CKD patients not on dialysis continues to decline - NephrOnline |
|
|
NephrOnlineIn the renal anemia market, the use of erythropoietin stimulating agents (ESAs) in patients with chronic kidney disease, not on dialysis (CKD-ND) continues ... read more |